Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Drion

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Current Pharmaceutical Design|March 15, 2006
From the design to the clinical application of thromboxane modulatorsJean-Michel Dogné, Julien Hanson, Xavier de Leval, et al.
British Journal of Haematology|October 20, 2010
CHIC cells: a novel ALK+ cell line derived from a relapsed anaplastic large cell lymphomaCaroline Thielen, Bettina Bisig, Stéphanie Gofflot, et al.
Acta Biomaterialia|April 23, 2023
Structural and functional heterogeneity of mineralized fibrocartilage at the Achilles tendon-bone insertionAlexandra Tits, Stéphane Blouin, Maximilian Rummler, et al.
Scientific Reports|August 17, 2021
Local anisotropy in mineralized fibrocartilage and subchondral bone beneath the tendon-bone interfaceAlexandra Tits, Erwan Plougonven, Stéphane Blouin, et al.
Current Drug Targets|December 30, 2017
Therapeutic Applications of Prostaglandins and Thromboxane A2 Inhibitors in Abdominal Aortic AneurysmsAudrey Courtois, Georgios Makrygiannis, Jean-Paul Cheramy-Bien, et al.
Plos One|November 22, 2014
Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantationMarilène Binsfeld, Yves Beguin, Ludovic Belle, et al.
Macromolecular Bioscience|August 9, 2011
In vivo biocompatibility of three potential intraperitoneal implantsSylvie Defrère, Mélanie Mestagdt, Raphaël Riva, et al.
Microbes and Infection|November 21, 2007
Natural antibody--complement dependent neutralization of bovine herpesvirus 4 by human serumBénédicte Machiels, Laurent Gillet, Sieberth Do Nascimento Brito, et al.
Oncoimmunology|June 23, 2017
Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effectsGrégory Ehx, Gilles Fransolet, Laurence de Leval, et al.
Prostaglandins & Other Lipid Mediators|March 15, 2011
BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthaseCéline Cherdon, Stéphanie Rolin, Julien Hanson, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Current Pharmaceutical Design|March 15, 2006
From the design to the clinical application of thromboxane modulatorsJean-Michel Dogné, Julien Hanson, Xavier de Leval, et al.
British Journal of Haematology|October 20, 2010
CHIC cells: a novel ALK+ cell line derived from a relapsed anaplastic large cell lymphomaCaroline Thielen, Bettina Bisig, Stéphanie Gofflot, et al.
Acta Biomaterialia|April 23, 2023
Structural and functional heterogeneity of mineralized fibrocartilage at the Achilles tendon-bone insertionAlexandra Tits, Stéphane Blouin, Maximilian Rummler, et al.
Scientific Reports|August 17, 2021
Local anisotropy in mineralized fibrocartilage and subchondral bone beneath the tendon-bone interfaceAlexandra Tits, Erwan Plougonven, Stéphane Blouin, et al.
Current Drug Targets|December 30, 2017
Therapeutic Applications of Prostaglandins and Thromboxane A2 Inhibitors in Abdominal Aortic AneurysmsAudrey Courtois, Georgios Makrygiannis, Jean-Paul Cheramy-Bien, et al.
Plos One|November 22, 2014
Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantationMarilène Binsfeld, Yves Beguin, Ludovic Belle, et al.
Macromolecular Bioscience|August 9, 2011
In vivo biocompatibility of three potential intraperitoneal implantsSylvie Defrère, Mélanie Mestagdt, Raphaël Riva, et al.
Microbes and Infection|November 21, 2007
Natural antibody--complement dependent neutralization of bovine herpesvirus 4 by human serumBénédicte Machiels, Laurent Gillet, Sieberth Do Nascimento Brito, et al.
Oncoimmunology|June 23, 2017
Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effectsGrégory Ehx, Gilles Fransolet, Laurence de Leval, et al.
Prostaglandins & Other Lipid Mediators|March 15, 2011
BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthaseCéline Cherdon, Stéphanie Rolin, Julien Hanson, et al.
Pageof 5